A recent study revealed that in bladder cancer, TERT promoter mutation appeared to be a potential predictive marker of response to Bacillus Calmette‐Guérin treatment which was regarded as one of the first and most successful oncological immunotherapy.29 The gene discussed is TERT; the disease is urinary bladder cancer.